Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Oral baricitinib is effective and safe for treating alopecia areata.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Tislelizumab can cause cutaneous lupus erythematosus.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Ruxolitinib helped a man regrow his beard after years of hair loss.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

CDK4/6 inhibitors generally maintain quality of life in metastatic breast cancer patients, except for some side effects like diarrhea and hair loss.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Cilostazol may help hair grow and could be a new treatment for hair loss.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.